other
US federal agency that reviews and approves drugs, biologics, and medical devices, and oversees food safety, clinical trials, and manufacturing standards.
No evidence-backed relationships are recorded.
Stem cell entrepreneur Chuck Meeker predicts a series of FDA roundtables on his industry's therapies before the end of the year. The agency declined to say whether any are planned, so for now the forecast tells us more about what the industry hopes than about what the FDA intends.
Reality
The panel was unanimous that Grail's Galleri is safe and divided six to four on whether it is effective, on evidence in which 287 of more than 35,000 people screened got a cancer signal and about 60 percent of those were diagnosed.
Perspective Coverage
3 publishersReality
FDA Chief Scientist Steven Kozlowski says aging and longevity will be focus areas in the regulatory science report the agency issues in fiscal 2027. His larger aim is a shared, qualified endpoint for aging that any developer could use to run a trial and seek approval.
Reality
Eli Lilly's 367-person trial found the top dose of tirzepatide plus eloralintide cut body weight 23.3%, against 14.8% on tirzepatide alone. Dropout ran far higher on the combination, so nobody has yet measured how much of that gain holds across everyone prescribed the pair.
Reality
GLP-1 prescriptions for obese children aged 8 to 11 have risen 310-fold since 2019, a transplant surgeon's study found. The surgeon wants severe cases treated early but concedes that long-term data on growth and puberty are still missing.
Reality
AriBio's October Phase 3 readout for AR1001 decides whether Fosun Pharma adds $80 million to the $60 million option fee it paid in May. Among the Korean biotech events due that month, it is the one that ties a partner's cash directly to trial data.
Reality
Korea Atomic Energy Research Institute's home-built RFT-30 cyclotron has cut Korea's reliance on imported zirconium-89 from 100% to under 5%. The institute also ships the isotope abroad, where its cyclotron research head says U.S. FDA approval could lift demand much further.
Reality
Penn State engineers are surface-modifying sterile-filtration membranes to remove microbes from injectable drugs, in work published in Biotechnology Journal. Doctoral candidate Shreya Kapila's own test for a new filter is that it removes organisms while leaving little of an expensive drug behind in the membrane.
Reality
E. coli survived longer in poultry-amended Georgia onion soils than in untreated soil across two seasons, a Risk Analysis study found. Humidity went with longer survival and wind with shorter, so growers' food-safety plans may need to reflect local weather.
Reality
Nature's editors want AI medical devices tested in real clinics, noting that just 19 of some 4,600 clinical AI papers were prospective randomized trials. Until the FDA decides, hospitals need to check whether a vendor's accuracy figure came from real patients or from a simulation.
Reality
Harvard's lung-on-a-chip has nearly 5,400 citations since 2010, but most non-animal test methods have yet to be rigorously tested, IEEE Spectrum reports. Validation means head-to-head runs against animal experiments, so animal data remains the yardstick for now.
Reality
SWANS, described in Science, sent faint pulses about 40 centimeters through a rat's tissue to switch on a nerve-stimulating implant in its hind leg. Dropping the radio shrinks the devices to syringe size, though that range was measured only in rats.
Reality
Washington University researchers found 22 near-daily cannabis users with drug-resistant epilepsy had more than twice the convulsive seizures of 42 nonusers. The chart review cannot prove cause, but it puts heavy THC use into the clinical history.
Reality
Chinese groups are developing 82% of the 140 in vivo CAR-T drugs in animal or human testing, a Boston Consulting Group analysis found. Developers elsewhere can expect the field's first clinical evidence, and much of its competition, to come from Chinese trials.
Reality
Precision Neuroscience raised $250 million at just over a $1 billion valuation, $42.5 million of it from Bill Ackman's Pershing Square and his institute. The other $207.5 million came in undisclosed amounts, so the round names its generalist investors without showing what they paid.
Reality
HLB's US unit Elevar won FDA approval for Rifiktu 21 months after licensing it from Relay Therapeutics, a first for a Korean company filing directly. Elevar will sell the bile-duct cancer drug without a partner from the fourth quarter, in a second-line niche worth roughly $81 million a year at most.
Reality
CTX310, a one-time CRISPR infusion, cut LDL by 52.5% and triglycerides by 47.8% after 12 months at its top dose in a Cleveland Clinic trial. Its 15 patients are enough to show the effect lasts but too few to rule out rare harms or to show it can replace lipid drugs.
Reality
ST Pharm signed three oligonucleotide contracts worth $182 million this year, each above $50 million, a size it did not reach once last year. Its earnings case now rests on commercial reorders, with the largest contract tied by industry estimates to a single Ionis drug, Tryngolza.
Reality
PNOE's 2.0 mask, due October 1, lets gym members run an eight-minute metabolic breath test without a trained operator. At gyms with no staff on the floor, members will use the test on their own, and PNOE's software will be the only thing explaining the results.
Reality
The companies say intismeran plus Keytruda slowed melanoma's return after surgery in the first randomized Phase 3 test of neoantigen vaccines. No detailed data has been released.
Perspective Coverage
4 publishersReality
Science · August 26, 2026 · 3 publishers
Invest · September 25, 2026 · 1 publisher
Science · September 25, 2026 · 1 publisher
Invest · September 19, 2026 · 1 publisher
Science · September 12, 2026 · 1 publisher
Product · September 2, 2026 · 1 publisher
Science · August 27, 2026 · 1 publisher
Build · August 24, 2026 · 1 publisher
Invest · August 23, 2026 · 1 publisher
Build · August 21, 2026 · 1 publisher
Invest · August 21, 2026 · 1 publisher
Science · August 20, 2026 · 1 publisher
Science · August 20, 2026 · 1 publisher
Science · August 19, 2026 · 1 publisher
Science · August 18, 2026 · 1 publisher
Product · August 17, 2026 · 4 publishers
Science · August 16, 2026 · 1 publisher